328 related articles for article (PubMed ID: 2645190)
1. Glucagonlike peptide I (7-37) actions on endocrine pancreas.
Weir GC; Mojsov S; Hendrick GK; Habener JF
Diabetes; 1989 Mar; 38(3):338-42. PubMed ID: 2645190
[TBL] [Abstract][Full Text] [Related]
2. Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.
Mojsov S; Weir GC; Habener JF
J Clin Invest; 1987 Feb; 79(2):616-9. PubMed ID: 3543057
[TBL] [Abstract][Full Text] [Related]
3. Effects of glucagonlike peptide I-(7-36) on release of insulin, glucagon, and somatostatin by rat pancreatic islet cell monolayer cultures.
D'Alessio DA; Fujimoto WY; Ensinck JW
Diabetes; 1989 Dec; 38(12):1534-8. PubMed ID: 2573553
[TBL] [Abstract][Full Text] [Related]
4. Glucagonostatic and insulinotropic action of glucagonlike peptide I-(7-36)-amide.
Komatsu R; Matsuyama T; Namba M; Watanabe N; Itoh H; Kono N; Tarui S
Diabetes; 1989 Jul; 38(7):902-5. PubMed ID: 2661287
[TBL] [Abstract][Full Text] [Related]
5. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.
Fehmann HC; Göke R; Göke B; Bächle R; Wagner B; Arnold R
Biochim Biophys Acta; 1991 Feb; 1091(3):356-63. PubMed ID: 1705823
[TBL] [Abstract][Full Text] [Related]
6. Interaction of glucagon-like peptide-1(7-36) amide and gastric inhibitory polypeptide or cholecystokinin on insulin and glucagon secretion from the isolated perfused rat pancreas.
Suzuki S; Kawai K; Ohashi S; Watanabe Y; Yamashita K
Metabolism; 1992 Apr; 41(4):359-63. PubMed ID: 1556941
[TBL] [Abstract][Full Text] [Related]
7. Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas.
Suzuki S; Kawai K; Ohashi S; Mukai H; Murayama Y; Yamashita K
Diabetes; 1990 Nov; 39(11):1320-5. PubMed ID: 2146178
[TBL] [Abstract][Full Text] [Related]
8. Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7-37) on a somatostatin secreting cell line.
Fehmann HC; Habener JF
FEBS Lett; 1991 Feb; 279(2):335-40. PubMed ID: 1672112
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-1 (7-36 amide): a potent glucagonostatic and insulinotropic hormone.
Matsuyama T; Komatsu R; Namba M; Watanabe N; Itoh H; Tarui S
Diabetes Res Clin Pract; 1988 Oct; 5(4):281-4. PubMed ID: 3069410
[TBL] [Abstract][Full Text] [Related]
10. GLP-1(7-36) amide stimulates insulin secretion in rat islets: studies on the mode of action.
Fridolf T; Ahrén B
Diabetes Res; 1991 Apr; 16(4):185-91. PubMed ID: 1802486
[TBL] [Abstract][Full Text] [Related]
11. Effects of glucagon-like peptide 1 (7-36) amide and glucagon on amylin release from perfused rat pancreas.
Inoue K; Hisatomi A; Umeda F; Nawata H
Horm Metab Res; 1991 Sep; 23(9):407-9. PubMed ID: 1743611
[TBL] [Abstract][Full Text] [Related]
12. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
Parkes DG; Pittner R; Jodka C; Smith P; Young A
Metabolism; 2001 May; 50(5):583-9. PubMed ID: 11319721
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S
Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604
[TBL] [Abstract][Full Text] [Related]
14. Intra-islet regulation of hormone secretion by glucagon-like peptide-1-(7--36) amide.
Heller RS; Aponte GW
Am J Physiol; 1995 Dec; 269(6 Pt 1):G852-60. PubMed ID: 8572216
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases.
Kawai K; Suzuki S; Ohashi S; Mukai H; Ohmori H; Murayama Y; Yamashita K
Endocrinology; 1989 Apr; 124(4):1768-73. PubMed ID: 2564338
[TBL] [Abstract][Full Text] [Related]
16. The structure-function relationship of GLP-1 related peptides in the endocrine function of the canine pancreas.
Ohneda A; Ohneda K; Ohneda M; Koizumi F; Ohashi S; Kawai K; Suzuki S
Tohoku J Exp Med; 1991 Nov; 165(3):209-21. PubMed ID: 1807008
[TBL] [Abstract][Full Text] [Related]
17. Synergistic stimulatory effect of glucagon-like peptide-1 (7-36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas.
Fehmann HC; Göke B; Göke R; Trautmann ME; Arnold R
FEBS Lett; 1989 Jul; 252(1-2):109-12. PubMed ID: 2668027
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagonlike peptide-1 (7-37).
Hosokawa YA; Hosokawa H; Chen C; Leahy JL
J Clin Invest; 1996 Jan; 97(1):180-6. PubMed ID: 8550831
[TBL] [Abstract][Full Text] [Related]
19. Glucose-dependency of the insulin stimulatory effect of glucagon-like peptide-1 (7-36) amide on the rat pancreas.
Göke R; Wagner B; Fehmann HC; Göke B
Res Exp Med (Berl); 1993; 193(2):97-103. PubMed ID: 8516568
[TBL] [Abstract][Full Text] [Related]
20. GLP-1(7-36)amide-stimulated insulin secretion in rat islets is sodium-dependent.
Fridolf T; Ahrén B
Biochem Biophys Res Commun; 1991 Aug; 179(1):701-6. PubMed ID: 1883392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
